Thyroid function, pulmonary arterial hypertension and scleroderma

被引：3
|
作者：
Marasini, B [1 ]
Massarotti, M [1 ]
Cossutta, R [1 ]
机构：
[1] Univ Milan, Ist Clin Humanitas, Rheumatol Unit, Dept Med Surg & Dent, Milan, Italy
来源：
AMERICAN JOURNAL OF MEDICINE | 2005年 / 118卷 / 03期
关键词：
D O I：
10.1016/j.amjmed.2004.09.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [21] Pulmonary Function Test Parameters in Scleroderma With and Without Pulmonary Hypertension
    Yap, Vanessa
    Zantah, Massa
    Foley, Raymond
    Datta, Debapriya
    CHEST, 2017, 152 (04) : 990A - 990A
  • [22] Limited Scleroderma-Induced Pulmonary Arterial Hypertension Resulting in Impaired Postoperative Respiratory Function
    Shah, Farhan A.
    Mahler, Nathan
    Braford, Michalla
    Greene, Nelson
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [23] Clinical and Hemodynamic Features of Scleroderma Patients with Pulmonary Venous Hypertension Versus Pulmonary Arterial Hypertension
    Gordon, Jessica K.
    Doobay, Kamini
    Horn, Evelyn
    Bolster, Marcy B.
    Shapiro, Lee S.
    Khanna, Dinesh
    Frech, Tracy M.
    Fields, Kara
    Derk, Chris T.
    Hummers, Laura K.
    Mayes, Maureen D.
    Steen, Virginia D.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S673 - S674
  • [24] EFFICACY OF IMATINIB MESYLATE ON SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 238 - 239
  • [25] Treatment of pulmonary arterial hypertension due to scleroderma: Challenges for the future
    Rubin, Lewis J.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (01) : 191 - +
  • [26] Diagnosing and managing scleroderma-related pulmonary arterial hypertension
    Athanasiou, Katherine Alexis
    Sahni, Sonu
    Rana, Amrinder
    Talwar, Arunabh
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (09): : 11 - 18
  • [27] Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension
    Shah, Ami A.
    Wigley, Fredrick M.
    Hummers, Laura K.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 98 - 104
  • [28] Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension
    Deidda, Martino
    Piras, Cristina
    Dessalvi, Christian Cadeddu
    Locci, Emanuela
    Barberini, Luigi
    Orofino, Susanne
    Musu, Mario
    Mura, Mario Nicola
    Manconi, Paolo Emilio
    Finco, Gabriele
    Atzori, Luigi
    Mercuro, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 241 : 401 - 406
  • [29] Risk assessment in Scleroderma-associated pulmonary arterial hypertension
    Mercurio, Valentina
    Diab, Nermin
    Peloquin, Grace
    Housten-Harris, Traci
    Damico, Rachel
    Kolb, Todd M.
    Mathai, Stephen C.
    Hassoun, Paul M.
    VASCULAR PHARMACOLOGY, 2020, 132
  • [30] Efficacy of Imatinib Mesylate on Scleroderma Associated Pulmonary Arterial Hypertension
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Asada, K.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    Nagai, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S212 - S213
12345